標(biāo)題: Titlebook: Advances in Radiation Oncology; Jeffrey Y.C. Wong,Timothy E. Schultheiss,Eric H. R Book 2017 Springer International Publishing AG 2017 Ima [打印本頁] 作者: culinary 時間: 2025-3-21 18:47
書目名稱Advances in Radiation Oncology影響因子(影響力)
書目名稱Advances in Radiation Oncology影響因子(影響力)學(xué)科排名
書目名稱Advances in Radiation Oncology網(wǎng)絡(luò)公開度
書目名稱Advances in Radiation Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Advances in Radiation Oncology被引頻次
書目名稱Advances in Radiation Oncology被引頻次學(xué)科排名
書目名稱Advances in Radiation Oncology年度引用
書目名稱Advances in Radiation Oncology年度引用學(xué)科排名
書目名稱Advances in Radiation Oncology讀者反饋
書目名稱Advances in Radiation Oncology讀者反饋學(xué)科排名
作者: 毀壞 時間: 2025-3-21 21:42 作者: Banister 時間: 2025-3-22 01:11 作者: 真實的人 時間: 2025-3-22 08:12 作者: arthroplasty 時間: 2025-3-22 12:21
Intensity-Modulated Proton Beam Therapy of Prostate Cancer-History, Results, and Future Directions,harged subatomic particles (i.e., low entrance dose and lack of exit dose) to deliver highly conformal radiation therapy with a lower integral dose (dose to normal tissue) than can be achieved with photon-based treatments. Proton beam radiation therapy first became available on an extremely limited 作者: crease 時間: 2025-3-22 15:23 作者: Anthology 時間: 2025-3-22 18:02
The Impact of IGRT on Normal Tissue Toxicity, planned treatment geometry and the daily set-up. This agreement includes both the patient position and the localization of the internal target and normal structures. This process reduces non-tumor tissues within the target volume to a minimum. IGRT is now commonly accompanied by altered fractionati作者: jovial 時間: 2025-3-23 01:02 作者: 生命層 時間: 2025-3-23 01:42
Cancer Stem Cells and Tumor Microenvironment in Radiotherapy,tients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefi作者: 共同生活 時間: 2025-3-23 08:41
Biomarkers and Radiotherapy, on molecules implicated in the cell cycle, DNA repair pathways, and apoptosis as radiation is known to affect such pathways. More recent data has focused on big data, i.e.—omics (genomics, proteomics, etc.) to find a molecular signature that predicts response to radiation as well as identify those 作者: Ankylo- 時間: 2025-3-23 12:19 作者: Nebulizer 時間: 2025-3-23 17:07
Mathematical Modeling in Radiation Oncology,e boundaries of the tumor, but also to the unique biology of the patient’s disease. In recent years, mathematical modeling has made inroads toward achieving these goals, through the optimization of radiation dose based on radiobiological parameters for individual patients. In this chapter, we review作者: Mast-Cell 時間: 2025-3-23 22:01
https://doi.org/10.1007/978-3-319-53235-6Image guided radiotherapy; MRI guided focused ultrasound; MRI guided radiotherapy; Radiation oncology; S作者: ALE 時間: 2025-3-24 00:35
978-3-319-85098-6Springer International Publishing AG 2017作者: Corral 時間: 2025-3-24 04:50
Jeffrey Y.C. Wong,Timothy E. Schultheiss,Eric H. ROffers comprehensive coverage of magnetic resonance imaging (MRI)-guided therapies.Reviews the potential role of radiotherapy in enhancing immunotherapy.Discusses systems and mathematical biology appr作者: 收到 時間: 2025-3-24 10:32
Cancer Treatment and Researchhttp://image.papertrans.cn/a/image/149534.jpg作者: 惡名聲 時間: 2025-3-24 12:43 作者: Essential 時間: 2025-3-24 15:37
Clinical Presentations of Melanomas a strategy to elicit immunosuppression in preparation for allogeneic transplant. Over the past decade, the purview of localized radiation therapy has been expanded to include a role as an adjuvant to immunotherapy. It is now recognized that radiation therapy to a tumor has the potential of convert作者: kidney 時間: 2025-3-24 22:39
Dirk J. Ruiter,Kees Welvaart,Soldano Ferronens, predicting the duration of this interval can be difficult. The clinical course for these patients is dependent on myriad factors including the primary histology, size, and location of metastatic lesions. Attempts have been made to model prognosis based on other factors such as response to neoadj作者: 變異 時間: 2025-3-25 02:09
Histopathological Aspects of Dysplastic Nevi is superior to what can be obtained with computed tomography (CT), the modality used most often to support radiation therapy treatment simulation. There are a number of critical challenges to employing MR for simulation imaging, namely the reduced spatial fidelity, and the lack of a direct relation作者: 凹室 時間: 2025-3-25 05:36 作者: 按時間順序 時間: 2025-3-25 09:58
Zsolt Argenyi M.D.,Chris H. Jokinen M.D.harged subatomic particles (i.e., low entrance dose and lack of exit dose) to deliver highly conformal radiation therapy with a lower integral dose (dose to normal tissue) than can be achieved with photon-based treatments. Proton beam radiation therapy first became available on an extremely limited 作者: 某人 時間: 2025-3-25 12:56
https://doi.org/10.1007/978-1-60327-582-8ng normal tissue. Known as hypofractionated radiation therapy (HRT), or stereotactic ablative radiation therapy (SABR), this technique has been developed in multiple sites outside the brain, including lung, prostate, and pancreas. Accompanying such treatment is some form of image guided radiation th作者: 拾落穗 時間: 2025-3-25 16:16 作者: set598 時間: 2025-3-25 21:08
https://doi.org/10.1007/978-1-4612-6076-9dly changing with radiotherapy now playing an integral part of systemic therapy in patients with metastatic disease. Stereotactic body radiotherapy to each oligometastatic site is now actively being evaluated as a means to more definitively control disease and contribute to a longer progression free作者: 尊嚴(yán) 時間: 2025-3-26 03:26
Cuticle Techniques in Arthropodstients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefi作者: 盡管 時間: 2025-3-26 08:12 作者: 持續(xù) 時間: 2025-3-26 08:39
Ana Pais,Jorge Lino Alves,Jorge Belinhang by ionizing radiations; these findings have prompted the idea that drugs that emulate these DDR deficiencies might serve as clinically useful radiosensitizers for improving results in cancer therapy. In this chapter, the ways in which several agents now established as radiosensitizers do in fact 作者: Multiple 時間: 2025-3-26 13:34 作者: nonradioactive 時間: 2025-3-26 19:38
0927-3042 erapy in enhancing immunotherapy thanks to the broader immune-stimulatory effects, ?how cancer stem cells and the tumor microenvironment influence response, and the application of mathematical and systems biolo978-3-319-85098-6978-3-319-53235-6Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: euphoria 時間: 2025-3-26 23:27
Combining Radiotherapy and Immunotherapy,e tumor control. We summarize the current knowledge of radiation therapy’s effects on the immune system, including results from preclinical and clinical trials, as well as future directions in combining radiotherapy and immunotherapy.作者: 補充 時間: 2025-3-27 02:33
SBRT and the Treatment of Oligometastatic Disease,th systemic therapy. In the past 20?years since the conception of the oligometastatic hypothesis, there have been advances in surgical and radiation therapy techniques resulting in reduced toxicities. Additionally, developments in systemic therapy have prolonged survival for patients with metastatic作者: 傲慢物 時間: 2025-3-27 08:19
MRI Guided Radiotherapy,nto the treatment room. Integrating MR with patient positioning and monitoring before and during treatment, respectively, would potentially improve radiation therapy treatment accuracy, enabling tighter uncertainty margins and ultimately improving outcomes. The challenges of integrating a MRI system作者: Gentry 時間: 2025-3-27 13:24
Oncologic Applications of Magnetic Resonance Guided Focused Ultrasound,ding prostate, breast, gynecologic, gastrointestinal and brain cancers, and soft tissue tumors are in active development. This chapter provides an overview of MRgFUS including biological effects and physical parameters description. A comprehensive review of all currently approved and evolving oncolo作者: maroon 時間: 2025-3-27 15:19 作者: jaundiced 時間: 2025-3-27 20:47
Biologic and Image Guided Systemic Radiotherapy,alogs or immunologically guided as in the case of radiolabeled antibodies directed against tumor associated antigens. Recent advances in intensity modulated radiation therapy allow for radiation dose sculpting to the entire body resulting in a more targeted form of total body irradiation, also refer作者: 鳥籠 時間: 2025-3-27 23:31
Cancer Stem Cells and Tumor Microenvironment in Radiotherapy,mplexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major “R”s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or 作者: LAVE 時間: 2025-3-28 03:15 作者: Fsh238 時間: 2025-3-28 07:34
Dirk J. Ruiter,Kees Welvaart,Soldano Ferroneth systemic therapy. In the past 20?years since the conception of the oligometastatic hypothesis, there have been advances in surgical and radiation therapy techniques resulting in reduced toxicities. Additionally, developments in systemic therapy have prolonged survival for patients with metastatic作者: 洞穴 時間: 2025-3-28 11:29 作者: Ventricle 時間: 2025-3-28 14:51 作者: gerrymander 時間: 2025-3-28 22:46 作者: ectropion 時間: 2025-3-29 02:13 作者: 閑蕩 時間: 2025-3-29 06:57 作者: GEON 時間: 2025-3-29 08:21 作者: 政府 時間: 2025-3-29 12:30
IGRT and Hypofractionation for Primary Tumors,erapy (IGRT). Localization of these tumors requires high quality soft tissue imaging, in addition to the ability to ascertain tumor location . radiation delivery. This chapter will outline the role of IGRT as it pertains to HRT treatment schemes for various malignancies.作者: 痛得哭了 時間: 2025-3-29 18:25 作者: Eosinophils 時間: 2025-3-29 22:29
Biomarkers and Radiotherapy,who may have increased risk of radiation induced toxicities. While many potential biomarkers in assessing radiation response have been researched this chapter is a start to providing information on biomarkers used in clinical practice.作者: Ossification 時間: 2025-3-30 02:02
The Mammalian DNA Damage Response as a Target for Therapeutic Gain in Radiation Oncology,function by inhibiting parts of the DDR are first presented. The various subsystems of the DDR are next reviewed, and several potential molecular targets for discovery or design of chemical modifiers that could lead novel radiosensitizing drugs are discussed.作者: adj憂郁的 時間: 2025-3-30 06:49 作者: Compassionate 時間: 2025-3-30 09:17
0927-3042 mmunotherapy.Discusses systems and mathematical biology appr.This book concisely reviews important advances in radiation oncology, providing practicing radiation oncologists with a fundamental understanding of each topic and an appreciation of its significance for the future of radiation oncology. I
